← Back to All Filings

COMPASS Pathways (CMPS) Insider Filing: New Director Joins Board

Low SignificanceOctober 31, 2025 at 7:02:07 PM EDT

COMPASS Pathways plc

$CMPS3CIK: 0001816590

Subscribe to track CMPS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

COMPASS Pathways (CMPS) Insider Filing: New Director Joins Board

Company: COMPASS Pathways plc (CMPS) Form: 3 | Filed: 2025-10-31 Significance: Low

Insider: JONAS JEFFREY M Title: Director | Relationship: Director

Transaction: • Type: Initial Statement of Ownership • Shares: 0 • Price: N/A • Value: $0 • Owned After: 0

Key Insight: A new director, Jeffrey M. Jonas, has joined the board and filed an initial statement of ownership, reporting no current holdings in the company.

Market Context: This Form 3 establishes a baseline for a new insider. Future purchases will be noteworthy as they would represent the director's first open-market acquisitions.

Comprehensive Analysis

SEC Filing Analysis: COMPASS Pathways plc (CMPS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Jeffrey M. Jonas has been appointed as a new director at COMPASS Pathways plc and, as of the filing date, holds no shares of the company.
  • Market Impact: Neutral. This is an informational filing establishing a new insider's baseline ownership and does not represent a market transaction.

Company Information

FieldValue
CompanyCOMPASS Pathways plc
Ticker SymbolCMPS
CIK0001816590
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameJONAS JEFFREY M
CIK0001042021
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type3
Transaction Date2025-10-29
Transaction Codenull
Security TypeNo securities owned
Shares Involved0
Price Per Sharenull
Total Value$0
Shares Owned After0
Ownership Typenull

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted0
% of Shares Outstanding0.00%
Post-Transaction Ownership0 shares (0.00% of outstanding)
Materiality AssessmentNot Applicable (Informational Filing)

Impact Evaluation

  • Market Cap Context: COMPASS Pathways is a small-cap company with a $0.63 billion market cap. While this initial filing has no financial value, the company's size means any future insider transactions could be material.
  • Ownership Concentration: The new director currently has zero ownership concentration. This filing sets a baseline from which any future accumulation of shares will be measured.
  • Dilution Impact: Not applicable as there are no equity grants or options involved in this filing.
  • Transaction Significance: The significance is low as this is a required administrative filing for a new director, not a transactional event reflecting market sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A Form 3 is a statement of initial ownership. The appointment of a new director may be viewed positively for governance, but the filing itself simply reports a starting ownership of zero and has no direct market impact.

Volume & Sentiment

  • Expected Volume Impact: None. This type of filing does not typically influence trading volume.
  • Sentiment Indicator: Neutral. The filing is procedural.

Investment Insights

Positive Market Indicators

  • The appointment of a new director can be a positive signal for corporate governance and strategic direction.

Risk Factors

  • This filing itself presents no new risks.

Key Takeaways

  1. New Director: A new director, Jeffrey M. Jonas, has joined the board of COMPASS Pathways.
  2. Zero Ownership: This is an initial Form 3 filing, reporting zero beneficial ownership as of the effective date.
  3. Baseline Established: This filing establishes a baseline; any future purchases by this insider would be their first and could be interpreted as a signal of confidence.

Additional Context

Transaction Notes

  • The filing indicates the insider held no securities as of 2025-10-29, the date of the event that triggered the filing requirement, which is the appointment to the board.
Topics:#SECFiling#InsiderTrading#CMPS#CMPSStock#Form3#CorporateGovernance#Biotech#Investing#StockMarket#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.